iRhythm Holdings, Inc.

IRTC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014
Operating Activities
Net Income $-29.7M $-20.9M $-22.8M $-15.8M
Depreciation & Amortization $1.6M $568.0K $492.0K $242.0K
Depreciation — — — —
Amortization — — — —
Stock-Based Compensation $9.8M $1.9M $1.4M $828.0K
Net Cash from Operating Activities $-14.9M $-16.7M $-18.0M $-15.6M
Investing Activities
Capital Expenditures $3.6M $2.8M $1.8M $539.0K
Business Acquisitions — — — —
Net Cash from Investing Activities $-34.7M $-68.2M — —
Financing Activities
Dividends Paid — — — —
Stock Repurchases — — — —
Net Cash from Financing Activities $6.5M $111.3M — —
Net Change in Cash $-43.1M $26.4M — —
Free Cash Flow $-18.5M $-19.4M $-19.8M $-16.2M
← Newer Page 2 of 2 Older →